Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Specific Optimized Therapy Post-Market Clinical Follow-up Study

NCT03481413 is registered in ClinicalTrials.gov with EPD Solutions, A Philips Company as lead sponsor.

NCT NCT03481413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03481413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Specific Optimized Therapy Post-Market Clinical Follow-up Study
Lead sponsor
EPD Solutions, A Philips Company
Phase
Observational
Overall status
Terminated
Start date
November 30, 2018
Completion date
March 30, 2023
Enrollment
566 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

arrythmia